Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 16.02.2026 3 Ann Surg Oncol 1 Arch Pathol Lab Med 1 Cancer Res 1 Gene 2 J Am Acad Dermatol 1 J Invest Dermatol 3 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. MAYHEW MM, Witt RG
   ASO Author Reflections: Risk Estimation vs. Real-World Practice: SLNB Decision-Making in Thin Melanoma.
   Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19199.
   PubMed        
   
   
2. RIAZ N, Bagge RO
   ASO Author Reflections: Refining Prognosis in Stage III Cutaneous Melanoma with Non-nodal Regional Metastases.
   Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19238.
   PubMed        
   
   
3. BIRGIN E, Rahbari NN
   Continuous Robotic Ultrasound Hepatectomy (CRUSH): A Novel Approach for Parenchyma-Sparing Liver Surgery.
   Ann Surg Oncol. 2026;33:2551-2552.
   PubMed         Abstract available
   
   

   
   Arch Pathol Lab Med

4. IRFAN A, Khazaeli M, Milton DR, Nagarajan P, et al
   CD274 Alterations and PD-L1 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Patients With Melanoma: Relationships to Histopathologic Features and Outcomes.
   Arch Pathol Lab Med. 2026 Feb 9:earpa.2025-0467.
   PubMed         Abstract available
   
   

   
   Cancer Res

5. XU X, Liu X, Jarajapu V, Neelature Sriramareddy S, et al
   A Multi-Step Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma.
   Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-2684.
   PubMed         Abstract available
   
   

   
   Gene

6. CHEN Y, Wang Q, Shi Y, Chen J, et al
   Kojic acid inhibits melanoma progression by targeting the MYC-CCNA2/KPNA2 axis.
   Gene. 2026 Feb 12:150047. doi: 10.1016/j.gene.2026.150047.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

7. HWANG JC, Huhmann LB, Perez D, Kim DY, et al
   Parkinson's disease and risk of melanoma in United States Veterans: A Veterans Affairs Cancer Registry retrospective cohort study.
   J Am Acad Dermatol. 2026 Feb 12:S0190-9622(26)00223.
   PubMed        
   
   
8. JOSHI TP, Sheth S, Dokic Y, Orengo IF, et al
   Factors impacting melanoma transection and outcomes of patients with transected melanomas: a population-based study of the Surveillance, Epidemiology, and End Results Program.
   J Am Acad Dermatol. 2026 Feb 5:S0190-9622(26)00136.
   PubMed        
   
   

   
   J Invest Dermatol

9. RIZO-POTAU D, Fornies-Marine A, Villanueva-Canas JL, Aguilar M, et al
   Exploring global cfDNA fragmentomics as a biomarker in real-world melanoma patients.
   J Invest Dermatol. 2026 Feb 6:S0022-202X(26)00079.
   PubMed         Abstract available
   
   

   
   Melanoma Res

10. BROWNE FJ, Bollard SM, Ormond P, Kelleher F, et al
    Melanoma: a genetics guide for surgeons.
    Melanoma Res. 2026 Feb 16. doi: 10.1097/CMR.0000000000001082.
    PubMed         Abstract available
    
    
11. DEVOLDERE A, Bouche O, Barbe C, Didier K, et al
    Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3.
    Melanoma Res. 2026 Feb 16. doi: 10.1097/CMR.0000000000001083.
    PubMed         Abstract available
    
    
12. KRISTJANSEN KA, Mensel C, Larsen MO, Dam-Dalgeir G, et al
    Safety of tranexamic acid in patients with stage III melanoma undergoing lymph node dissection: a retrospective cohort study.
    Melanoma Res. 2026 Feb 11. doi: 10.1097/CMR.0000000000001084.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum